Ad26.cov2-s/albumin-humanLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1929卷 / 1期

关键词：

D O I：

10.1007/s40278-022-25640-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：16 / 16

相关论文

共 50 条

[1] Albumin-humanLack of efficacy: case report
Reactions Weekly, 2023, 1946 (1) : 25 - 25
[2] Albumin-humanLack of efficacy: case report
Reactions Weekly, 2025, 2044 (1) : 19 - 19
[3] Albumin-humanLack of efficacy
Reactions Weekly, 2024, 2002 (1) : 27 - 27
[4] Albumin-humanLack of efficacy in NMDA receptor encephalitis: case report
Reactions Weekly, 2021, 1869 (1) : 20 - 20
[5] Ad26.cov2-s/elasomeranDRESS syndrome: case report
Reactions Weekly, 2022, 1927 (1) : 20 - 20
[6] Ad26.CoV2-S/heparinVarious toxicities: case report
Reactions Weekly, 2021, 1882 (1) : 23 - 23
[7] Ad26.cov2-s/elasomeranLack of efficacy:2 case reports
Reactions Weekly, 2023, 1942 (1) : 17 - 17
[8] Ad26.cov2-s/elasomeranRecurrent generalised anhidrosis: case report
Reactions Weekly, 2023, 1957 (1) : 17 - 17
[9] Ad26.COV2-S/COVID-19-Vaccine-Pfizer-BioNTechLack of efficacy: case report
Reactions Weekly, 2021, 1866 (1) : 15 - 15
[10] Ad26.cov2-s/methylprednisoloneAntineutrophil cytoplasmic autoantibodies associated glomerulonephritis and lack of efficacy: case report
Reactions Weekly, 2022, 1923 (1) : 20 - 20

← 1 2 3 4 5 →